RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 61 filers reported holding RECRO PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $487,000 | -23.2% | 300,427 | -62.5% | 0.00% | 0.0% |
Q2 2022 | $634,000 | -58.9% | 800,661 | -6.8% | 0.00% | -66.7% |
Q1 2022 | $1,544,000 | -1.3% | 859,039 | -6.2% | 0.00% | +50.0% |
Q4 2021 | $1,564,000 | +56.1% | 915,745 | +87.9% | 0.00% | 0.0% |
Q3 2021 | $1,002,000 | -21.5% | 487,270 | -12.0% | 0.00% | 0.0% |
Q2 2021 | $1,276,000 | -19.5% | 553,592 | -2.7% | 0.00% | -33.3% |
Q1 2021 | $1,586,000 | -1.7% | 569,022 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $1,614,000 | +1693.3% | 567,258 | +1200.0% | 0.00% | – |
Q3 2020 | $90,000 | -89.1% | 43,634 | -76.1% | 0.00% | -100.0% |
Q2 2020 | $828,000 | +114.5% | 182,406 | +284.5% | 0.00% | +100.0% |
Q1 2020 | $386,000 | -81.1% | 47,438 | -57.4% | 0.00% | -75.0% |
Q4 2019 | $2,043,000 | +391.1% | 111,459 | +196.9% | 0.00% | +300.0% |
Q3 2019 | $416,000 | +766.7% | 37,544 | +674.4% | 0.00% | – |
Q2 2019 | $48,000 | +29.7% | 4,848 | -34.9% | 0.00% | – |
Q2 2018 | $37,000 | +117.6% | 7,443 | +396.2% | 0.00% | – |
Q1 2018 | $17,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |